| Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC) YK Chae, S Chang, T Ko, J Anker, S Agte, W Iams, WM Choi, K Lee, ... Scientific reports 8 (1), 2918, 2018 | 239 | 2018 |
| Clinical and immunological implications of frameshift mutations in lung cancer Journal of Thoracic Oncology, 2019 | 35 | 2019 |
| Mass spectrometry-based serum proteomic signature as a potential biomarker for survival in patients with non-small cell lung cancer receiving immunotherapy YK Chae, W Bin Kim, AA Davis, LC Park, JF Anker, NI Simon, K Rhee, ... Translational Lung Cancer Research 9 (4), 1015-1028, 2020 | 15 | 2020 |
| Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC). Sci Rep. 2018; 8: 2918 YK Chae, S Chang, T Ko, J Anker, S Agte, W Iams, WM Choi, K Lee, ... | 10 | |
| Immunologic and clinical implications of harboring mutations in mismatch repair (MMR) genes in non-small cell lung cancer (NSCLC) YK Chae, K Rhee, LC Park, A Cho, T Ko, S Chang, A Davis, M Bhave, ... Cancer Research 78 (13_Supplement), 4608-4608, 2018 | 3 | 2018 |
| P1. 04-01 Impact of Chromatin Remodeling Genes Including SMARCA2 and PBRM1 on Neoantigen and Immune Landscape of NSCLC LC Park, S Chang, T Ko, K Rhee, J Anker, M Bhave, A Davis, M Cruz, ... Journal of Thoracic Oncology 13 (10), S525, 2018 | 2 | 2018 |
| A Sweet and Salty Milieu: The Utility of CT in Bilateral Adrenal Hemorrhage M Tavares, R Sittol, SM Chang, G Otuonye, T Barnes Journal of the Endocrine Society 4 (Issue Supplement_1), 2020 | 1 | 2020 |
| The Great Masquerade: Bladder Cancer in the Pancreas JS Park, SM Chang, S Kancherla American College of Gastroenterology, 2020 | | 2020 |
| P2. 11-06 Serum Proteomic Signature as a Potential Biomarker for Survival in Patients with NSCLC Receiving Immunotherapy WB Kim, P Viveiros, J Anker, N Simon, K Rhee, J Song, A Cho, S Chang, ... Journal of Thoracic Oncology 14 (10), S793-S794, 2019 | | 2019 |
| Pembrolizumab induced multiple immune related adverse events including myasthenia gravis, hepatitis and thyroiditis in a patient with thymoma MD Kyunghoon Rhee, MD Taeyeong ko, MD Sangmin Chang, ... Journal for ImmunoTherapy of Cancer 2018 6, p568, 2018 | | 2018 |
| Frameshift indel selectively correlates with immunotherapy outcome for advanced NSCLC MD Wungki Park, MD Lee Chun Park, MD Vaia Florou, MD Diana Saravia, ... Journal for ImmunoTherapy of Cancer 2018 6, p586, 2018 | | 2018 |
| MA19.04 The Clinical Implication of Frameshift Indel Mutation Burden in Non-Small Cell Lung Cancer (NSCLC) G Chae, Y.K. & Park, W & Saravia, D & Florou, V & Chang, S & Wang, S & Chiec ... Journal of Thoracic Oncology 13 (10), S423, 2018 | | 2018 |
| Immunologic and clinical implications of polymerase delta (POLD) and Polymerase epsilon (POLE) gene mutations in non-small cell lung cancer (NSCLC) YK Chae, K Rhee, LC Park, A Cho, S Chang, T Ko, A Davis, M Bhave, ... CANCER RESEARCH 78 (13), 2018 | | 2018 |
| WNT/β-catenin pathway is inversely correlated with activated CD8 T cell infiltration in non-small cell lung cancer (NSCLC) MC YK Chae , T Ko , S Chang , J Anker , S Agte , W Iams Journal for ImmunoTherapy of Cancer 2017 5, 86, 2017 | | 2017 |
| Epithelial-mesenchymal transition (EMT) signature was inversely associated with activated CD8 infiltration in non-small cell lung cancer (NSCLC) MC YK Chae, S Chang, T Ko, J Anker, S Agte, W Iams Journal for ImmunoTherapy of Cancer 2017 5, 86, 2017 | | 2017 |
